SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Centers for Disease Control and Prevention (CDC). Trends in deaths from systemic lupus erythematosus: United States, 1979–1998. MMWR Morb Mortal Wkly Rep 2002; 51: 3714.
  • 2
    Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 2003; 18: 203946.
  • 3
    Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, et al, and the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 15260.
  • 4
    Alarcon GS, McGwin G Jr, Petri M, Reveille JD, Ramsey-Goldman R, Kimberly RP, and the PROFILE Study Group. Baseline characteristics of a multiethnic lupus cohort: PROFILE [published erratum appears in Lupus 2002;11:402]. Lupus 2002; 11: 95101.
  • 5
    Alarcon GS, McGwin G Jr, Sanchez ML, Bastian HM, Fessler BJ, Friedman AW, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum 2004; 51: 737.
  • 6
    Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001; 45: 191202.
  • 7
    Yelin EH, Such CL, Criswell LA, Epstein WV. Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. Med Care 1998; 36: 51322.
  • 8
    Criswell LA, Such CL, Yelin EH. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 1997; 24: 228390.
  • 9
    Ward MM, Leigh JP, Fries JF. Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspecialty care. Arch Intern Med 1993; 153: 222937.
  • 10
    Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK, Kucken LE, et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996; 335: 7919.
  • 11
    Escarce JJ, Epstein KR, Colby DC, Schwartz JS. Racial differences in the elderly's use of medical procedures and diagnostic tests. Am J Public Health 1993; 83: 94854.
  • 12
    Wilson MG, May DS, Kelly JJ. Racial differences in the use of total knee arthroplasty for osteoarthritis among older Americans. Ethn Dis 1994; 4: 5767.
  • 13
    MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000; 284: 98492.
  • 14
    Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum 2001; 44: 150414.
  • 15
    Katz JN, Barrett J, Liang MH, Kaplan H, Roberts WN, Baron JA. Utilization of rheumatology physician services by the elderly. Am J Med 1998; 105: 3128.
  • 16
    Odutola J, Ward MM. Ethnic and socioeconomic disparities in health among patients with rheumatic disease [review]. Curr Opin Rheumatol 2005; 17: 14752.
  • 17
    Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus: identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 84953.
  • 18
    Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797806.
  • 19
    Calvo-Alen J, Reveille JD, Rodriguez-Valverde V, McGwin G Jr, Baethge BA, Friedman AW. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003; 12: 37785.
  • 20
    Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis 2006; 65: 15005.
  • 21
    Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 5663.
  • 22
    Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003; 12: 2806.
  • 23
    Ward MM, Marx AS, Barry NN. The rating scale preference measure as an evaluative measure in systemic lupus erythematosus. Lupus 2000; 9: 696701.
  • 24
    Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, et al. The Medical Expenditure Panel Survey: a national information resource. Inquiry 1996–1997; 33: 37389.
  • 25
    National Center for Health Statistics. Survey description document. In: 2002 National Health Interview Survey. Hyattsville (MD): Centers for Disease Control and Prevention; 2003. URL: ftp://ftp.cdc.gov/pub/HealthStatistics/NCHS/DatasetDocumentation/NHIS/2002/srvydesc.pdf.
  • 26
    Urowitz MB, Kagal A, Rahman P, Gladman DD. Role of specialty care in the management of patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 120710.
  • 27
    Sanchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Diaz J, Moreno-Coutino G, Cravioto MC. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001; 111: 4648.
  • 28
    Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, et al. Who is at greatest risk for receiving poor-quality health care? N Engl J Med 2006; 354: 114756.
  • 29
    Waidmann TA, Rajan S. Race and ethnic disparities in health care access and utilization: an examination of state variation. Med Care Res Rev 2000; 57 Suppl 1: 5584.